.406 Ventures
IntroColdCheck size: TBDContacts: Kathryn, Jeremy FrieseLast contact: 2026-02-11
Next step: Waiting on Kathryn's reply; activate Jeremy Friese warm intro
Meetings
0No meetings recorded yet.
Top Concern
None surfaced
Overview
- Stage focus: Early stage
- Check size: TBD
- Healthcare thesis: Healthcare AI (per Thomas's research)
- Key people: Kathryn (contact from Thomas's outreach), Jeremy Friese (CEO — we know him)
Relationship History
| Date | Type | Notes |
|---|---|---|
| Feb 11 | Cold outreach | Thomas emailed Kathryn. Pitched deployment layer for AI in healthcare, UM focus, $2M seed. Asked for 15 min. |
Status
- Current stage: Outreach — waiting on response
- Next step: Waiting on Kathryn's reply
- Temperature: Cold outreach, but we have a warm path through Jeremy Friese
What They Care About
- Early stage healthcare AI
Portfolio
- Humata Health (Jeremy Friese) — prior auth platform, $25M round. We know Jeremy.
Notes
- Important: Michael knows Jeremy Friese, CEO of Humata Health — a .406 portfolio company. Thomas cold-emailed Kathryn, but Jeremy is the warm path into this fund. He could vouch for us and make a direct intro.
- Jeremy is not .406's CEO — he's a portfolio founder. But that's arguably better — a founder reference carries weight with VCs.